SCHEMBL25663222

SCHEMBL25663222

c1ccc2c(c1)sc1nc(-c3ccc(N(c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4)c4ccc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc4)cc3)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.35
▸ NPC1 O15118 5/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ LIMK1 P53667 2/20 0.34
▸ HPGD P15428 4/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ APP P05067 2/20 0.33
▸ GPR3 P46089 1/20 0.33
▸ MAPT P10636 5/20 0.32
▸ PIM3 Q86V86 1/20 0.32
▸ ROCK1 Q13464 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ ATM Q13315 2/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ TLR9 Q9NR96 2/20 0.31
▸ MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663220 0.92 RAB9A (0.38) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663221 0.92 RAB9A (0.39) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL24055864 0.91 NPC1 (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663228 0.90 ALDH1A1 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663224 0.89 RAB9A (0.33) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663226 0.89 RAB9A (0.33) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL24055544 0.88 CYP1A1 (0.37) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663211 0.87 NPC1 (0.32) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL24056281 0.86 NPC1 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1
SCHEMBL25663218 0.86 APP (0.35) RAB9ANPC1SMN1; SMN2ALDH1A1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 RAB9A 2198/4885NPC1 3859/4885SMN1; SMN2 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback